OS Therapies Schedules United Kingdom’s Medicines and Healthcare products Regulatory Agency’s (MHRA) Scientific Advice Meeting in the Third Quarter of 2025 for Review of its OST-HER2 Immunotherapy Candidate for Osteosarcoma

OS Therapies Schedules United Kingdom’s Medicines and Healthcare products Regulatory Agency’s (MHRA) Scientific Advice Meeting in the Third Quarter of 2025 for Review of its OST-HER2 Immunotherapy Candidate for Osteosarcoma

NEW YORK, March 11, 2025–(BUSINESS WIRE)–OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies…

Continue Reading
AMA among organizations asking RFK Jr. to reschedule immunization meeting

AMA among organizations asking RFK Jr. to reschedule immunization meeting

RFK Jr. speaks before the Senate Education Health Labor and Pensions Committee during his nomination as HHS secretary.…

Continue Reading
Spencer Cummings with Bladen County Hospital Discusses Rural Healthcare Growth at Local Chamber Meeting –

Spencer Cummings with Bladen County Hospital Discusses Rural Healthcare Growth at Local Chamber Meeting –

A staff report  On March 19, 2024, Spencer Cummings, the President of Bladen County Hospital-Cape Fear…

Continue Reading